Opendata, web and dolomites

Reminova02

Feasibility Study to Demonstrate Effectiveness and Efficiency of Enamel Remineralisation using Reminova's EAER (Electrically Accelerated Enhanced Remineralisation) Technology for Dental Applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Reminova02 project word cloud

Explore the words cloud of the Reminova02 project. It provides you a very rough idea of what is the project "Reminova02" about.

population    lesions    dentists    replacing    globally    minute    tissue    eaer    teeth    maintains    commercial    viability    curative    repairs    customer    2008    frame    precavitated    economy    global    initial    anticipated    optimise    embrace    caries    tiny    believe    solution    60bn    feasibility    retain    lifetime    health    disease    15    accelerated    keen    electric    office    welcomed    validate    planning    36    enhanced    opposed    device    suitable    methodology    subsequent    techniques    shift    dentistry    meet    optimisation    formulations    effectiveness    regrows    scalability    building    tooth    filling    organisation    treat    reparative    remineralisation    entry    reminova    preventative    communicable    removal    painless    decay    patients    consumers    first    crisis    adult    treatment    rapid    critical    drilling    claims    market    anaesthesia    4bn    award    pull    public    dental    time    enamel    electrically    unperceivable    world    core    timeframes   

Project "Reminova02" data sheet

The following table provides information about the project.

Coordinator
REMINOVA LTD 

Organization address
address: DENTAL INNOVATION AND TRANSLATION CENTRE INVERALMOND BUSINESS CENTRE 6 AULD BOND ROAD
city: PERTH
postcode: PH1 3FX
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.reminova.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-05-01   to  2016-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REMINOVA LTD UK (PERTH) coordinator 50˙000.00

Map

 Project objective

'Dental caries (tooth decay) is the most common communicable disease, globally affecting 36% of the adult population. It has been identified by the World Health Organisation (WHO) as a major global public health crisis (2008) and costs the European economy an estimated at €60Bn. Reminova is developing technology that 'regrows' enamel, replacing the need for dental anaesthesia and drilling in the treatment of caries. The novel approach requires the delivery of three formulations to the tooth using a tiny (unperceivable) electric current in a process known as Electrically Accelerated Enhanced Remineralisation (EAER). This will be used to treat caries in-office without the need for tooth tissue removal. Our development has been welcomed by both end consumers and the dentistry sector and there is a strong market pull to get our technology to market. Patients want a painless solution that maintains and repairs their teeth, so they may retain them throughout their lifetime. Dentists are keen to embrace a shift to preventative and curative dentistry as opposed to the current reparative approach used when drilling and filling teeth. To achieve market success it is anticipated the device should control rapid remineralisation of precavitated lesions within existing timeframes and treatment pathways. This Phase 1 H2020 award would be used to undertake initial feasibility work and planning on how we can optimise remineralisation to a 15 minute time-frame. We believe that this is critical to the commercial viability and scalability of an identified €1.7–4.4Bn global market in the first 3 years of market entry for the device. The core activities of our phase 1 project would be initial feasibility work on techniques for optimisation and building a suitable approach and methodology for a subsequent phase 2 application. This will be essential to demonstrate the effectiveness of the technology to meet customer needs and validate market claims, thus achieving commercial success. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REMINOVA02" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REMINOVA02" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

INFINITE (2015)

INnovative laser machine For INdustrial engravIng and 3d TExturing

Read More  

NANOHIGH (2015)

High volume production facility for high accuracy nanocapsules

Read More  

STROBE (2015)

Sustained Release Ocular Bevacizumab for the treatment of wet acute macular degeneration

Read More